Product/Service

Biotech Experience: Drug Development Experience For Biotechs

GettyImages-1288978528 Scientist Using Microscope In Lab

Leverage our extensive expertise across over 120 therapeutic indications to drive your success.

Over the past three decades Avance Clinical has been at the forefront of biotech clinical research across more than 120 therapeutic indications. The experience gained over these years guides and informs client decision-making at every stage to maximize the success of clinical research and achievement of trial outcomes.

While Avance Clinical has built up a wealth of knowledge, relationships with sites and specialists, and patient advocacy groups across these therapeutic areas it also has a strong focus on Cell & Gene Therapies, Central Nervous System (CNS), Dermatology, Endocrinology, Infectious Diseases, Oncology, Ophthalmology, Rare Disease & Orphan Drug, and Respiratory & Allergy indications.

BIOTECH Specialists

Avance Clinical has specialist gene technology accreditation (Office of Gene Technology Regulator [OGTR] in Australia) and is experienced in managing cell and gene therapy trials globally for its biotech clients.

The clinical operations, project management, and scientific and regulatory affairs teams offer decades of deep clinical research management experience across Australia, New Zealand, Asia, North America, and Europe.

Our Areas of Expertise And Experience

  • Central nervous system

  • Dermatology

  • Endocrinology

  • Haematology

  • Hepatology

  • Immunology

  • Infectious diseases

  • Metabolism & nutritional disorders

  • Oncology

  • Ophthalmology

  • Otorhinolaryngology (ENT)

  • Rare & orphan indications

  • Respiratory, allergy, thoracic & mediastinal disorders

  • Sexual dysfunction & disorders

Why Biotechs Choose Avance Clinical

More than three decades of deep clinical research management experience, Avance Clinical is the largest
specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand, Asia and North America for international biotechs.

  • 43.5% REBATE

  • 5-6 Wks START-UP TIME

  • 100% CAPABILITIES

  • FDA COMPLIANT RESEARCH